Research Grants Awarded

Reseach grants support Minnesota scientific and medical research that has the potential to translate to clinical advances in regenerative medicine. Grants typically open every September. Learn more about how to apply for a grant by reading our frequently asked questions

 

View research grants awarded by year.
Wenqian Hu, PhD
A major problem in leukemia treatment is the rise of drug-resistant mutations in the genome of cancer cells, which makes many well-designed cancer…
2019-2021
Leigh Griffiths, DVM, PhD
Minnesota Department of Health statistics indicate that almost 100,000 Minnesotan’s are currently affected by ischemic heart disease (IHD),…
2019-2021
Jonathan Finnoff, DO
Musculoskeletal injuries and diseases are the main cause of disability in the U.S. Platelet Rich Plasma (PRP) is defined as an autologous blood…
2019-2021
LaTonya Hickson, MD
Diabetic kidney disease (DKD) is the most common cause of kidney failure in the U.S. and has no adequate cure. Mesenchymal stromal cell (MSC)…
2019-2021
Troy C. Lund, MD, PhD
Successful bone marrow transplant is the only way to cure a number of cancers, bone marrow failure syndromes, and other serious blood disease (like…
2018-2020
Joseph Lillegard, MD, Phd
Hereditary Tyrosinemia Type 1 (HT1) is a genetic disorder that can lead to liver and kidney failure, and is fatal without treatment. There is no…
2018-2020
Daniel Garry, MD, PhD
Cardiovascular disease is the most common cause of death in the United States, and many patients need heart transplants to survive. Currently,…
2018-2020
Terrence C. Burns, MD, PhD
The decline of memory and thinking processes seen in aging, neurodegenerative diseases (like Alzheimer’s disease), and exposure of the brain to…
2018-2020
Raghavendra Rao, MD
Each year in the United States, 12,000 extremely preterm infants (birth before 28 weeks of pregnancy) develop bleeding within the brain soon after…
2018-2020
Robert Tranquillo, PhD
Millions of U.S. citizens suffer from vein valve insufficiency, often resulting in chronic leg ulcers that cause pain, immobility, and a reduced…
2018-2020
Marija Cvetanovic, PhD
Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease with no available therapies. This proposal will determine therapeutic…
2018-2020
Alexander Revzin, PhD
The goal of this project is to develop microcapsules that could be used as cell carriers during differentiation of stem cells into pancreatic…
2018-2020